[go: up one dir, main page]

MX2014014898A - Sistemas y metodos de identificacion de agentes cosmeticos para composiciones para el cuidado del cabello/cuero cabelludo. - Google Patents

Sistemas y metodos de identificacion de agentes cosmeticos para composiciones para el cuidado del cabello/cuero cabelludo.

Info

Publication number
MX2014014898A
MX2014014898A MX2014014898A MX2014014898A MX2014014898A MX 2014014898 A MX2014014898 A MX 2014014898A MX 2014014898 A MX2014014898 A MX 2014014898A MX 2014014898 A MX2014014898 A MX 2014014898A MX 2014014898 A MX2014014898 A MX 2014014898A
Authority
MX
Mexico
Prior art keywords
systems
methods
hair
care compositions
cosmetic agents
Prior art date
Application number
MX2014014898A
Other languages
English (en)
Inventor
Robert Scott Youngquist
Ping Hu
Thomas Larry Dawnson Jr
Jun Xu
Robert Lloyd Binder
Theresa Dicolandrea
Brian Wilson Howard
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2014014898A publication Critical patent/MX2014014898A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cosmetics (AREA)

Abstract

Se proporcionan métodos y sistemas para determinar las relaciones funcionales entre un agente cosmético y una afección biológica capilar de interés. Se proporcionan, además, métodos y sistemas para identificar agentes cosméticos que afectan un estado de la biología del cabello, así como el uso de agentes identificados por tales métodos y sistemas para la preparación de composiciones cosméticas, productos para el cuidado personal, o ambos.
MX2014014898A 2012-06-06 2013-06-06 Sistemas y metodos de identificacion de agentes cosmeticos para composiciones para el cuidado del cabello/cuero cabelludo. MX2014014898A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261656218P 2012-06-06 2012-06-06
PCT/US2013/044497 WO2013184908A2 (en) 2012-06-06 2013-06-06 Systems and methods for identifying cosmetic agents for hair/scalp care compositions

Publications (1)

Publication Number Publication Date
MX2014014898A true MX2014014898A (es) 2015-03-04

Family

ID=48699278

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014014898A MX2014014898A (es) 2012-06-06 2013-06-06 Sistemas y metodos de identificacion de agentes cosmeticos para composiciones para el cuidado del cabello/cuero cabelludo.

Country Status (5)

Country Link
US (1) US9920357B2 (es)
EP (1) EP2859486A2 (es)
JP (1) JP2015527630A (es)
MX (1) MX2014014898A (es)
WO (1) WO2013184908A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5841234B2 (ja) 2011-03-31 2016-01-13 ザ プロクター アンド ギャンブルカンパニー フケ／脂漏性皮膚炎の治療に有効な皮膚活性剤を特定及び評価するためのシステム、モデル、及び方法
US9920357B2 (en) 2012-06-06 2018-03-20 The Procter & Gamble Company Systems and methods for identifying cosmetic agents for hair/scalp care compositions
US20180161389A1 (en) * 2015-01-09 2018-06-14 The Board Of Trustees Of The Leland Stanford Junior University R-spondin agonist-mediated hair growth
CN108713347B (zh) * 2016-10-28 2021-02-09 华为技术有限公司 一种通过用户设备接入网络的方法、装置及系统
CN108664769B (zh) * 2017-03-31 2021-09-21 中国科学院上海营养与健康研究所 基于癌症基因组和非特异性基因标签的药物重定位方法
US10610479B2 (en) * 2017-08-07 2020-04-07 Jan Marini Skin Research HYLA3D hyaluronic acid activating lip complex
CN112005305A (zh) * 2018-05-22 2020-11-27 宝洁公司 用于识别扰动因子与皮肤病症相关基因之间的关联的系统和方法
KR20200048738A (ko) 2018-10-30 2020-05-08 (주)아모레퍼시픽 Arid5b 발현 촉진 물질을 포함하는 피부 장벽기능 강화용 조성물 및 arid5b 촉진 물질의 스크리닝 방법
KR102682751B1 (ko) 2018-11-16 2024-07-12 (주)아모레퍼시픽 Endophilin A1 억제제를 포함하는 피부 미백용 조성물 및 피부 미백 물질의 스크리닝 방법
KR102370637B1 (ko) * 2019-01-15 2022-03-07 (주)바이오니아 Dkk1 유전자를 표적으로 하는 이중나선 올리고뉴클레오티드, 이를 포함하는 구조체 및 이를 포함하는 탈모 예방 또는 발모용 조성물
SG11202112030SA (en) * 2019-04-30 2021-12-30 Haplnscience Inc Composition for prevention or treatment of hair loss including hapln1
CN110144398A (zh) * 2019-06-21 2019-08-20 聊城市第二人民医院 用于开发阿尔茨海默诊断产品的分子标志物
CN112730831A (zh) * 2021-02-01 2021-04-30 上海大学 基于lepr单克隆抗体特异性识别细胞分选系统的应用
EP4369346A1 (en) * 2022-11-11 2024-05-15 Wella Germany GmbH Selection of a chemical compound applicable on a class of human hairs
CN119999566B (zh) * 2025-04-21 2025-07-11 江西立盾光电科技有限公司 一种植物工厂富硒水培生菜的种植方法
CN121276067A (zh) * 2025-12-08 2026-01-06 首都医科大学附属北京地坛医院 一种预测乙型肝炎相关肝衰竭患者继发感染的蛋白质组合、试剂盒及系统

Family Cites Families (158)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2694668A (en) 1952-03-10 1954-11-16 Abbott Lab Liquid multiple vitamin preparation and process of preparing the same
US2826551A (en) 1954-01-04 1958-03-11 Simoniz Co Nontangling shampoo
US2809971A (en) 1955-11-22 1957-10-15 Olin Mathieson Heavy-metal derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same
US3152046A (en) 1956-11-09 1964-10-06 Kapral Ales Maria Selenium disulfide dispersions
GB849433A (en) 1957-08-22 1960-09-28 Raymond Woolston Hair washing preparations
US3236733A (en) 1963-09-05 1966-02-22 Vanderbilt Co R T Method of combatting dandruff with pyridinethiones metal salts detergent compositions
US3761418A (en) 1967-09-27 1973-09-25 Procter & Gamble Detergent compositions containing particle deposition enhancing agents
US3694668A (en) 1970-01-02 1972-09-26 Bunker Ramo Track and hold system
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US3753196A (en) 1971-10-05 1973-08-14 Kulite Semiconductor Products Transducers employing integral protective coatings and supports
US3964500A (en) 1973-12-26 1976-06-22 Lever Brothers Company Lusterizing shampoo containing a polysiloxane and a hair-bodying agent
US4089945A (en) 1975-06-30 1978-05-16 The Procter & Gamble Company Antidandruff shampoos containing metallic cation complex to reduce in-use sulfide odor
US4323683A (en) 1980-02-07 1982-04-06 The Procter & Gamble Company Process for making pyridinethione salts
US4345080A (en) 1980-02-07 1982-08-17 The Procter & Gamble Company Pyridinethione salts and hair care compositions
US4379753A (en) 1980-02-07 1983-04-12 The Procter & Gamble Company Hair care compositions
US4470982A (en) 1980-12-22 1984-09-11 The Procter & Gamble Company Shampoo compositions
US4364837A (en) 1981-09-08 1982-12-21 Lever Brothers Company Shampoo compositions comprising saccharides
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
USRE34584E (en) 1984-11-09 1994-04-12 The Procter & Gamble Company Shampoo compositions
CA1261276A (en) 1984-11-09 1989-09-26 Mark B. Grote Shampoo compositions
US4677120A (en) 1985-07-31 1987-06-30 Molecular Design International Topical prodrugs for treatment of acne and skin diseases
US4967341A (en) 1986-02-14 1990-10-30 Hitachi, Ltd. Method and apparatus for processing data base
US4885107A (en) 1987-05-08 1989-12-05 The Procter & Gamble Company Shampoo compositions
US5124356A (en) 1987-06-29 1992-06-23 Molecular Design International, Inc. Dermal uses of trans-retinoids for the treatment of photoaging
USRE34075E (en) 1987-06-29 1992-09-22 Molecular Design International, Inc. Dermal uses of trans-retinoids for the treatment of cancer
US4885311A (en) 1987-06-29 1989-12-05 Molecular Design International Topical transretinoids for treatment of acne and skin diseases
US5049584A (en) 1988-12-14 1991-09-17 Molecular Design International Dermal uses of cis-retinoids for the treatment of cancer
US5106609A (en) 1990-05-01 1992-04-21 The Procter & Gamble Company Vehicle systems for use in cosmetic compositions
US5104646A (en) 1989-08-07 1992-04-14 The Procter & Gamble Company Vehicle systems for use in cosmetic compositions
US5297279A (en) 1990-05-30 1994-03-22 Texas Instruments Incorporated System and method for database management supporting object-oriented programming
US5624666A (en) 1995-01-20 1997-04-29 The Procter & Gamble Company Anti-dandruff shampoos with particulate active agent and cationic polymer
USD391162S (en) 1996-10-04 1998-02-24 The Procter & Gamble Company Combined jar and cover
FR2779058B1 (fr) 1998-05-29 2003-02-21 Dior Christian Parfums Utilisation d'au moins une saponine ou un sapogenol cosmetiquement acceptable, comme agent cosmetique destine a augmenter la quantite de collagene iv dans la jonction dermo-epidermique
US6974569B2 (en) 1999-05-03 2005-12-13 The Procter & Gamble Company Shampoos providing a superior combination anti-dandruff efficacy and condition
US6451300B1 (en) 1999-05-03 2002-09-17 The Procter & Gamble Company Anti-dandruff and conditioning shampoos containing polyalkylene glycols and cationic polymers
AU2001249098A1 (en) 2000-03-10 2001-09-24 Lifespan Biosciences, Inc. Nucleic acid sequences associated with aging, particularly skin aging
AU2001275018B2 (en) 2000-05-30 2008-04-03 Connective Tissue Imagineering Llc Composition and method for enhancing elasticity of tissue
FR2811226B1 (fr) 2000-06-05 2003-06-20 Clarins Laboratoires S A S Composition cosmetique hydratante comprenant un inhibiteur de trypsine vegetal
DE60115652T2 (de) 2000-07-10 2006-09-07 The Procter & Gamble Company, Cincinnati Kosmetische zusammensetzungen
FR2812190B1 (fr) 2000-07-28 2003-01-31 Oreal Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
US7001594B1 (en) 2000-10-10 2006-02-21 The Procter & Gamble Company Scalp cosmetic compositions and corresponding methods of application to provide scalp moisturization and skin active benefits
DE10100121A1 (de) 2001-01-03 2002-08-01 Henkel Kgaa Verfahren zur Bestimmung des Hautstreß oder der Hautalterung in vitro
JP2004535769A (ja) 2001-01-05 2004-12-02 インヴィトロジェン コーポレーション 結合した核酸の比較定量のための方法
EP1373504A2 (en) * 2001-01-08 2004-01-02 Interleukin Genetics, Inc. Mammalian tribbles signaling pathways and methods and reagents related thereto
US20020169562A1 (en) 2001-01-29 2002-11-14 Gregory Stephanopoulos Defining biological states and related genes, proteins and patterns
JP2005520483A (ja) 2001-05-09 2005-07-14 ユニバーシティ ホスピタルズ オブ クリーブランド 新規遺伝子マーカーを用いる皮膚に対する紫外線損傷の評価、それに関連する方法及び組成物
US7270828B2 (en) 2001-06-20 2007-09-18 The Procter & Gamble Company Personal care composition comprising hydrophobic gel
US20030170739A1 (en) 2001-11-08 2003-09-11 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Gene expression for analyzing photodamage
US20030088437A1 (en) 2001-11-08 2003-05-08 Iobst Susanne Teklits Method for identifying skin conditions, selecting suitable treatment products, or predicting product efficacy
FR2833827B1 (fr) 2001-12-21 2004-12-10 Oreal Procede d'evaluation de la region du contour de l'oeil et dispositif pour la mise en oeuvre d'un tel procede
ATE410203T1 (de) 2002-02-19 2008-10-15 Procter & Gamble Lipase-hemmende zusammensetzung
US6872401B2 (en) 2002-03-28 2005-03-29 L'oreal Cosmetic/dermatological compositions comprising a tetrahydrocurcuminoid and an amide oil
JP2005527904A (ja) 2002-05-20 2005-09-15 ロゼッタ インファーマティクス エルエルシー 複雑性疾患を構成疾患に細分するコンピュータ・システムおよび方法
JP2005529159A (ja) 2002-06-04 2005-09-29 ザ プロクター アンド ギャンブル カンパニー 選択陽イオン性コンディショニングポリマーを含有するコンディショニングシャンプー組成物
US20040175347A1 (en) 2003-03-04 2004-09-09 The Procter & Gamble Company Regulation of mammalian keratinous tissue using hexamidine compositions
WO2004080380A2 (fr) 2003-03-05 2004-09-23 L'oreal Utilisation de polyphenols catechniques pour la preparation de compositions destinees a favoriser la pigmentation naturelle de la peau
FR2853276B1 (fr) 2003-04-02 2007-05-18 Plastohm Sa Procede de realisation d'une reprise d'air dans un recipient multiparois
JP4789408B2 (ja) 2003-06-30 2011-10-12 株式会社 資生堂 目の形態分類方法及び形態分類マップ並びに目の化粧方法
AU2004283235B2 (en) 2003-10-06 2007-08-02 Novartis Ag Use of genetic polymorphisms that associate with efficacy of treatment of inflammatory disease
CN1874752A (zh) 2003-11-04 2006-12-06 宝洁公司 个人清洁组合物
US20050170378A1 (en) 2004-02-03 2005-08-04 Yakhini Zohar H. Methods and systems for joint analysis of array CGH data and gene expression data
USD535191S1 (en) 2004-04-27 2007-01-16 The Procter & Gamble Company Tube
FR2871061B1 (fr) 2004-06-04 2007-08-10 Coletica Sa Principe actif capable d'induire la transformation du tgbf- latent inactif en tgfb actif
USD542660S1 (en) 2004-06-18 2007-05-15 The Procter & Gamble Company Container
US8324447B2 (en) 2004-06-28 2012-12-04 Bar Ilan University Chimeric avian-based screening system containing mammalian grafts
USD516436S1 (en) 2004-08-27 2006-03-07 The Procter & Gamble Company Container
FR2874503B1 (fr) 2004-09-01 2006-11-24 Soc Ind Limousine Dapplication Biologique Silab Procede d'obtention d'un principe actif raffermissant et a visee anti-vergetures, actif obtenu et les fonctionnalites
US7531497B2 (en) 2004-10-08 2009-05-12 The Procter & Gamble Company Personal care composition containing a cleansing phase and a benefit phase
USD547193S1 (en) 2004-11-04 2007-07-24 The Procter & Gamble Company Product container
JP4415412B2 (ja) 2004-12-24 2010-02-17 ザ プロクター アンド ギャンブル カンパニー 吐出容器
US20060275237A1 (en) 2005-05-09 2006-12-07 Bissett Donald L Skin care compositions containing idebenone
US20070059685A1 (en) * 2005-06-03 2007-03-15 Kohne David E Method for producing improved results for applications which directly or indirectly utilize gene expression assay results
SA06270147B1 (ar) 2005-06-09 2009-12-22 نوفارتيس ايه جي عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين
WO2007027509A2 (en) * 2005-08-31 2007-03-08 Biogen Idec Ma Inc. Evaluating and treating scleroderma
US20100292085A1 (en) 2005-11-10 2010-11-18 Pek Yee Lum Methods and compositions for characterization of HSD1 inhibitors
FR2893252B1 (fr) 2005-11-17 2008-02-15 Engelhard Lyon Sa Extraits vegetaux stimulant has2
US8858968B2 (en) * 2005-12-05 2014-10-14 L'oreal Use of tyrosine-arginine dipeptide and niacinamide as substance P antagonist
CA2635650A1 (en) 2006-01-05 2007-07-12 Galderma Research & Development Acne lesions biomarkers and modulators thereof
US7727516B2 (en) 2006-02-28 2010-06-01 The Procter & Gamble Company Reduction of hair growth
WO2007111888A1 (en) 2006-03-22 2007-10-04 The Procter & Gamble Company Liquid treatment unitized dose composition
US20090098538A1 (en) 2006-03-31 2009-04-16 Glinsky Gennadi V Prognostic and diagnostic method for disease therapy
US7890267B2 (en) 2006-03-31 2011-02-15 Ordway Research Institute Prognostic and diagnostic method for cancer therapy
WO2007117466A2 (en) 2006-03-31 2007-10-18 Massachusetts Institute Of Technology Celastrol, gedunin, and derivatives thereof as hsp90 inhibitors
USD570707S1 (en) 2006-06-29 2008-06-10 The Procter & Gamble Company Lotion pump package
USD547661S1 (en) 2006-06-29 2007-07-31 The Procter & Gamble Company Cream jar
USD558591S1 (en) 2006-08-14 2008-01-01 The Procter & Gamble Company Bottle
WO2008021483A2 (en) 2006-08-17 2008-02-21 Ordway Research Institute Prognostic and diagnostic method for disease therapy
USD563221S1 (en) 2006-10-23 2008-03-04 The Procter & Gamble Company Cosmetic container
EP2120909A2 (en) 2006-12-15 2009-11-25 Ordway Research Institute Treatments of therapy-resistant diseases comprising drug combinations
WO2008086182A2 (en) 2007-01-04 2008-07-17 University Of Rochester Use of gene signatures to design novel cancer treatment regimens
WO2008086452A2 (en) 2007-01-10 2008-07-17 Columbia University Treatment and prevention of alzheimer's disease
US8580488B2 (en) 2007-02-05 2013-11-12 City Of Hope Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance
WO2008109717A1 (en) 2007-03-05 2008-09-12 Rutgers, The State University Of New Jersey Compositions and methods for treating cancer
US20090017080A1 (en) 2007-03-15 2009-01-15 Paul Robert Tanner Personal care kit having skin care compositions with a readily perceptible difference
JP2008245558A (ja) 2007-03-29 2008-10-16 Naris Cosmetics Co Ltd 抗老化素材の評価方法及びそれを配合した化粧料の製造方法
US20100256001A1 (en) 2007-04-03 2010-10-07 The Scripps Research Institute Blood biomarkers for mood disorders
ATE540676T1 (de) 2007-04-13 2012-01-15 Rikshospitalet Radiumhospitalet Hf Egfr-inhibitoren zur behandlung und diagnose von metastasierendem prostatakrebs
US7939253B2 (en) 2007-05-09 2011-05-10 The University Of Utah Research Foundation Methods and compositions for the diagnosis and treatment of ewing's sarcoma
WO2008144316A1 (en) 2007-05-14 2008-11-27 Indiana University Research And Technology Corporation Blood biomarkers for psychosis
US20100093611A1 (en) 2007-05-16 2010-04-15 Horrigan Stephen K Compounds and methods for treating or preventing autoimmune diseases
JP4424382B2 (ja) 2007-07-04 2010-03-03 ソニー株式会社 コンテンツ再生装置およびコンテンツ自動受信方法
US8106037B2 (en) 2007-08-03 2012-01-31 The Brigham And Women's Hospital, Inc. Identification and treatment of estrogen responsive prostate tumors
JP2010538680A (ja) 2007-09-19 2010-12-16 ザ トラスティーズ オブ ボストン ユニバーシティー 肺疾患に対する薬剤開発のための新規経路の同定
US20100298329A1 (en) 2007-09-19 2010-11-25 Massachusette Institute Of Technology Tolperisone and tolperisone-like drugs for the treatment of k-ras associated cancers
CN101152138B (zh) 2007-09-29 2010-12-29 天津盛世恒安科技发展有限公司 一种具有祛除妊娠纹功效的化妆制品及其制备方法
EP2188630A4 (en) 2007-10-02 2010-11-03 Univ Rochester METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC ANSWERS TO ONCOGENIC MUTATIONS
WO2009048747A2 (en) 2007-10-08 2009-04-16 Indiana University Research And Technology Corporation Candidate genes and blood biomarkers for bipolar mood disorder, alcoholism and stress disorder
US8535738B2 (en) 2007-12-20 2013-09-17 Elc Management, Llc Methods and compositions for treating skin
FR2925331B1 (fr) 2007-12-21 2010-04-09 Vincience Utilisation d'un hydrolysat de feve en tant que principe actif activateur de la synthese des aquaporines
WO2009102957A2 (en) 2008-02-14 2009-08-20 The Johns Hopkins University Methods to connect gene set expression profiles to drug sensitivity
US8392127B2 (en) 2008-03-22 2013-03-05 Merck Sharp & Dohme Corp. Methods and gene expression signature for assessing growth factor signaling pathway regulation status
FR2938341A1 (fr) 2008-11-13 2010-05-14 Galderma Res & Dev Modulateurs de la monoglyceride lipase dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee
BRPI0913578A2 (pt) 2008-05-14 2017-06-06 Dermtech Int diagnose de melanoma e lentigo solar por análise de ácido nucléico
EP2291791A4 (en) 2008-05-27 2011-06-22 Sloan Kettering Inst Cancer MODELS FOR COMBINATORY PERTURBATIONS OF LIVING BIOLOGICAL SYSTEMS
ATE509095T1 (de) 2008-05-28 2011-05-15 Symrise Ag Menschliches ex-vivo-hautmodell
WO2009149026A2 (en) 2008-06-01 2009-12-10 Tufts Medical Center, Inc. Genomic approaches to fetal treatment and diagnosis
JP5522717B2 (ja) 2008-09-19 2014-06-18 国立大学法人佐賀大学 アトピー性皮膚炎の検出方法および予防・治療剤のスクリーニング方法
US8831271B2 (en) 2008-10-07 2014-09-09 Ochanomizu University Subgraph detection device, subgraph detection method, program, data structure of data, and information recording medium
JP2010099015A (ja) 2008-10-24 2010-05-06 Shiseido Co Ltd ニキビ改善薬及びアトピー性皮膚炎改善剤のスクリーニング方法
WO2010062372A2 (en) 2008-11-03 2010-06-03 President And Fellows Of Harvard College Methods for modulating nf-kb using gibberellins
WO2010060055A1 (en) 2008-11-21 2010-05-27 Duke University Predicting cancer risk and treatment success
US8691866B2 (en) 2008-12-10 2014-04-08 The General Hospital Corporation HIF inhibitors and use thereof
JP2010172240A (ja) 2009-01-28 2010-08-12 Shiseido Co Ltd エラスチン発現低下を回復する薬剤のスクリーニング方法
US9676696B2 (en) 2009-01-29 2017-06-13 The Procter & Gamble Company Regulation of mammalian keratinous tissue using skin and/or hair care actives
US20100204325A1 (en) 2009-02-11 2010-08-12 Allergan, Inc. Valproic acid drug delivery systems and intraocular therapeutic uses thereof
US8557746B2 (en) 2009-04-01 2013-10-15 The General Hospital Corporation High throughput screens for small-molecule inhibitors of the nuclear receptor-like pathway regulating multidrug resistance in fungi
US20110010100A1 (en) 2009-07-07 2011-01-13 Yixue Li Functional domain analysis method and system
JP5513028B2 (ja) 2009-07-14 2014-06-04 花王株式会社 皮膚光損傷予防又は治癒剤の評価又は選択方法
FR2948021A1 (fr) 2009-07-16 2011-01-21 Oreal Utilisation cosmetique de polypeptides de type lacritine
KR101443927B1 (ko) 2009-08-20 2014-09-25 (주)아모레퍼시픽 헥사미딘류 및 레티노이드류를 함유하는 피부 개선 조성물
WO2011028819A1 (en) 2009-09-01 2011-03-10 The Trustees Of Columbia University In The City Of New York Synergistic transcription modules and uses thereof
US20120202840A1 (en) 2009-10-09 2012-08-09 University Health Network Use of Flubendazole and Vinca Alkaloids for Treatment of Hematological Diseases
WO2011041912A1 (en) 2009-10-09 2011-04-14 University Health Network Self-renewing single human hematopoietic stem cells, an early lymphoid progenitor and methods of enriching the same
JP5234666B2 (ja) 2009-12-11 2013-07-10 国立大学法人大阪大学 乾癬の判定のための測定方法
EP2512473A1 (en) 2009-12-17 2012-10-24 Vivolux Ab Tumour treatment agents and method
US20110150798A1 (en) 2009-12-21 2011-06-23 Sarah Bacus Compositions and methods for increasing cellular far and bleaching skin
WO2011103449A2 (en) 2010-02-19 2011-08-25 Mary Kay Inc. Topical skin care formulation
US20110217701A1 (en) 2010-03-03 2011-09-08 Carter Scott L Prognostic Marker for Endometrial Carcinoma
JP2013523154A (ja) 2010-04-06 2013-06-17 マサチューセッツ・インスティトュート・オブ・テクノロジー 転写物測定値数が減少した、遺伝子発現プロファイリング
BR112012026870A2 (pt) 2010-04-19 2017-01-10 Procter & Gamble assinaturas genéticas e chips de gene associados à administração de frequência de ráfsudio conduzida eletricamente à pele e métodos e tratamentos relacionados aos mesmos
WO2011137456A2 (en) 2010-04-30 2011-11-03 Hampton University Methods and mechanisms involving hyperpigmentation particularly for african american skin
CN103037692B (zh) 2010-05-20 2015-02-25 爱荷华大学研究基金会 用于抑制肌萎缩的方法
JP2012520349A (ja) 2010-07-22 2012-09-06 ザ プロクター アンド ギャンブル カンパニー フトコンブの抽出物を用いた色素過剰スポットの外観を改善するための方法
FR2963234B1 (fr) 2010-07-29 2020-07-17 Isp Investments Inc Utilisation d'une composition comprenant un extrait peptidique de feves pour stimuler la pousse des cheveux
US8965111B2 (en) 2010-09-09 2015-02-24 Nec Corporation Learning apparatus, a learning system, learning method and a learning program for object discrimination
PL2657250T3 (pl) 2010-12-21 2018-02-28 Cj Cheiljedang Corporation Odmiana polipeptydu posiadającego aktywność acetylotransferazy homoseryny oraz mikroorganizm wyrażający to samo
KR20140040690A (ko) 2011-01-31 2014-04-03 루콜라스-엠.디. 리미티드 미용학적 용도
JP2014513791A (ja) 2011-02-22 2014-06-05 ザ プロクター アンド ギャンブル カンパニー スキンケア組成物用の化粧剤を同定するための方法
JP5841234B2 (ja) 2011-03-31 2016-01-13 ザ プロクター アンド ギャンブルカンパニー フケ／脂漏性皮膚炎の治療に有効な皮膚活性剤を特定及び評価するためのシステム、モデル、及び方法
KR20130058107A (ko) 2011-11-25 2013-06-04 (주)아모레퍼시픽 콩으로부터 저분자 펩타이드 추출물을 분리하는 방법 및 이를 함유하는 화장료 조성물
US20130165470A1 (en) 2011-12-21 2013-06-27 The Procter & Gamble Company Methods for Detecting and Treating Rhinovirus Infection
US20130217589A1 (en) 2012-02-22 2013-08-22 Jun Xu Methods for identifying agents with desired biological activity
US10418127B2 (en) 2012-03-30 2019-09-17 The Procter & Gamble Company Method of formulating a skin-lightening composition
KR101458383B1 (ko) 2012-05-10 2014-11-05 한국콜마주식회사 도인발효추출물, 호박씨발효추출물 및 강화약쑥 추출물을 포함하는 피부 보습용 화장료 조성물
US9920357B2 (en) 2012-06-06 2018-03-20 The Procter & Gamble Company Systems and methods for identifying cosmetic agents for hair/scalp care compositions
JP6126216B2 (ja) 2012-06-18 2017-05-10 ザ プロクター アンド ギャンブル カンパニー 薬剤分野の老化防止利益を評価するための方法及びモデル
WO2014028572A2 (en) 2012-08-15 2014-02-20 The Procter & Gamble Company Systems, models and methods for identifying and evaluating skin-active agents effective for treating an array of skin disorders
EP3039159B1 (en) 2013-08-30 2017-10-04 The Procter and Gamble Company Methods of identifying cosmetic agents for treating periorbital dyschromia and systems therefor

Also Published As

Publication number Publication date
US20130331342A1 (en) 2013-12-12
JP2015527630A (ja) 2015-09-17
WO2013184908A3 (en) 2014-04-17
EP2859486A2 (en) 2015-04-15
US9920357B2 (en) 2018-03-20
WO2013184908A2 (en) 2013-12-12

Similar Documents

Publication Publication Date Title
MX2014014898A (es) Sistemas y metodos de identificacion de agentes cosmeticos para composiciones para el cuidado del cabello/cuero cabelludo.
WO2012116081A3 (en) Methods for identifying cosmetic agents for skin care compositions
EP3510993A4 (en) COSMETIC COMPOSITION FOR SKIN CARE
IN2015DN02939A (es)
WO2013075892A3 (de) Haarkonditionierende mittel
NZ714817A (en) Coated particles and compositions comprising same
EP3011046A4 (en) Customized skin care products and personal care products based on the analysis of skin flora
FR2998570B1 (fr) Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes
EP3052076A4 (en) Watery lotion skin care compositions and methods
FI20115758L (fi) Uusia viljatuotteita, niiden valmistus ja käyttö, ja niitä sisältäviä kosmeettisia formulaatioita
MX2014001893A (es) Metodos para reducir el olor.
BR112015014497A2 (pt) composição cosmética, método para aprimorar a característica de pele e utilização da composição.
BR112015014885A2 (pt) combinação de agentes ativos, composição cosmética e/ou dermatológica e processo para a preparação de uma composição de agentes ativos.
EP2870958A4 (en) MOISTURE CONTENT AND COSMETICS THEREWITH
IN2014DN08921A (es)
WO2013174774A3 (en) Cosmetic compositions comprising magnetosomes and uses thereof
SG11201507575QA (en) Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
BR112014032065A2 (pt) composição cosmética e/ou dermatológica, processo cosmético e uso cosmético da composição
MX385999B (es) Composiciones y métodos para tratamiento de la piel.
EP3510992A4 (en) SKIN-CREAMING COMPOSITION WITH MANNOSYL ETHYTROLIPOLIDE
BR112015010592A2 (pt) composição cosmética, processo para alisar as fibras de queratina e uso da composição
MX2014009750A (es) Composiciones antifungicas para el tratamiento de piel y uñas.
WO2010117709A3 (en) Peptide-based systems for delivery of costmetic agents
WO2012084336A3 (de) Haarbehandlungsmittel mit tensid(en) und kationischen keratinhydrolysat(en)
MX345263B (es) Formulación de pexiganan estable.